Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92,291 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of teneligliptin added to metformin in Chinese patients with type 2 diabetes mellitus inadequately controlled with metformin: A phase 3, randomized, double-blind, placebo-controlled study.
Ji L, Li L, Ma J, Li X, Li D, Meng B, Lu W, Sun J, Liu Y, Takayanagi G, Wang Y. Ji L, et al. Among authors: li d, li x, li l. Endocrinol Diabetes Metab. 2021 Jan 20;4(2):e00222. doi: 10.1002/edm2.222. eCollection 2021 Apr. Endocrinol Diabetes Metab. 2021. PMID: 33855222 Free PMC article. Clinical Trial.
Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study.
Zhu D, Gan S, Liu Y, Ma J, Dong X, Song W, Zeng J, Wang G, Zhao W, Zhang Q, Li Y, Fang H, Lv X, Shi Y, Tian H, Ji L, Gao X, Zhang L, Bao Y, Lei M, Li L, Zeng L, Li X, Hou X, Zhao Y, Hu T, Ge X, Zhao G, Li Y, Zhang Y, Chen L. Zhu D, et al. Among authors: li y, li x, li l. Lancet Diabetes Endocrinol. 2018 Aug;6(8):627-636. doi: 10.1016/S2213-8587(18)30105-0. Epub 2018 May 4. Lancet Diabetes Endocrinol. 2018. PMID: 29735394 Clinical Trial.
Determining the optimal fasting glucose target for patients with type 2 diabetes: Results of the multicentre, open-label, randomized-controlled FPG GOAL trial.
Yang W, Ma J, Yuan G, Li L, Zhang M, Lu Y, Ye X, Song W, Liu M, Wu J, Chen R, Li Y, Zhang X, Cui N, Yang J. Yang W, et al. Among authors: li y, li l. Diabetes Obes Metab. 2019 Aug;21(8):1973-1977. doi: 10.1111/dom.13733. Epub 2019 Jun 10. Diabetes Obes Metab. 2019. PMID: 30938035 Free PMC article. Clinical Trial.
Efficacy and safety of insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Asia Pacific insulin-naïve people with type 2 diabetes: The EDITION AP randomized controlled trial.
Ji L, Kang ES, Dong X, Li L, Yuan G, Shang S, Niemoeller E; EDITION AP trial investigators. Ji L, et al. Among authors: li l. Diabetes Obes Metab. 2020 Apr;22(4):612-621. doi: 10.1111/dom.13936. Epub 2019 Dec 26. Diabetes Obes Metab. 2020. PMID: 31797549 Free PMC article. Clinical Trial.
Chinese clinical guidelines for continuous glucose monitoring (2018 edition).
Bao Y, Chen L, Chen L, Dou J, Gao Z, Gao L, Guo L, Guo X, Ji L, Ji Q, Jia W, Kuang H, Li Q, Li Q, Li X, Li Y, Li L, Liu J, Ma J, Ran X, Shi L, Song G, Wang Y, Weng J, Xiao X, Xie Y, Xi G, Yang L, Zhao Z, Zhou J, Zhou Z, Zhu D, Zou D; Chinese Diabetes Society. Bao Y, et al. Among authors: li y, li x, li l, li q. Diabetes Metab Res Rev. 2019 Sep;35(6):e3152. doi: 10.1002/dmrr.3152. Epub 2019 Apr 25. Diabetes Metab Res Rev. 2019. PMID: 30884108 Review.
[Efficacy and safety of alogliptin in treatment of type 2 diabetes mellitus: a multicenter, randomized, double-blind, placebo-controlled phase III clinical trial in mainland China].
Pan C, Li W, Zeng J, Li C, Yang J, Ji Q, Lu J, Lyu X, Li X, Qu S, Xu X, Xue Y, Li L, Jiang Z, Zheng B, Bu R, Han P, Liu Y, Liu J, Peng Y, Liu X, Liu Z, Yan L, Lei M, Li X, Song Q, Shi B, Gu W, Li Z. Pan C, et al. Among authors: li c, li z, li w, li x, li l. Zhonghua Nei Ke Za Zhi. 2015 Nov;54(11):949-53. Zhonghua Nei Ke Za Zhi. 2015. PMID: 26759214 Clinical Trial. Chinese.
92,291 results
You have reached the last available page of results. Please see the User Guide for more information.